Insider Transactions in Q1 2023 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-0.8%
|
$576,000
$64.46 P/Share
|
|
Mar 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.33%
|
$1,575,000
$63.28 P/Share
|
|
Mar 15
2023
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.92%
|
$0
$0.43 P/Share
|
|
Mar 14
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.4%
|
$300,000
$60.1 P/Share
|
|
Mar 13
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-1.09%
|
$739,500
$58.03 P/Share
|
|
Mar 13
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.15%
|
$0
$0.46 P/Share
|
|
Mar 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,393
+39.35%
|
-
|
|
Mar 12
2023
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
430,517
+43.42%
|
-
|
|
Mar 12
2023
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
961,350
+43.33%
|
-
|
|
Mar 12
2023
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
292,584
+42.26%
|
-
|
|
Feb 27
2023
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.36%
|
$560,000
$56.8 P/Share
|
|
Feb 27
2023
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.87%
|
$0
$0.46 P/Share
|
|
Feb 21
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-6.45%
|
$495,000
$55.19 P/Share
|
|
Feb 18
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,412
+23.98%
|
-
|
|
Feb 18
2023
|
Andrew Hykes President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
46,549
+25.01%
|
-
|
|
Feb 18
2023
|
Thomas Tu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,412
+16.66%
|
-
|
|
Feb 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
50,000
-1.7%
|
$2,900,000
$58.24 P/Share
|
|
Feb 13
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-5.78%
|
$675,750
$53.95 P/Share
|
|
Feb 13
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+9.89%
|
$0
$0.46 P/Share
|
|
Jan 27
2023
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-1.82%
|
$610,000
$61.38 P/Share
|
|
Jan 27
2023
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+9.46%
|
$0
$0.46 P/Share
|
|
Jan 20
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-2.99%
|
$558,000
$62.01 P/Share
|
|
Jan 17
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
55,000
-1.04%
|
$3,630,000
$66.56 P/Share
|
|
Jan 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-4.23%
|
$841,500
$66.23 P/Share
|
|
Jan 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+9.07%
|
$0
$0.46 P/Share
|
|
Jan 01
2023
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,145
-0.56%
|
$72,135
$63.56 P/Share
|
|
Jan 01
2023
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,558
-0.19%
|
$98,154
$63.56 P/Share
|
|
Jan 01
2023
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,015
-0.59%
|
$63,945
$63.56 P/Share
|
|
Jan 01
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
782
-0.66%
|
$49,266
$63.56 P/Share
|